iRhythm Holdings, Inc. (IRTC)

NASDAQ: IRTC · USD

$124

+0.21 (+0.2%)· Recorded snapshot

Market cap	4.1B
Revenue (ttm)	825.3M
Net income (ttm)	-13.9M
EPS (ttm)	-$0.43
Shares out	33M
P/E (forward)	194.1x
Volume	470,138
Beta	1.46

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 825.3M
Net income (ttm): -13.9M
EPS (ttm): -$0.43
P/E (forward): 194.1x
Market cap: 4.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ถือ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E194.1

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-9.6

P25 n/aP50 n/aP75 n/a

ROIC0.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All IRTC indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

USD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001388658
Company name	iRhythm Holdings, Inc.
Country	United States
Country code	US
CUSIP number	450056106
Earnings date	2026-11-05
Earnings time	amc
Employees	2,400
Employees change	400
Employees growth	20%
Enterprise value	$4.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2006
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2016-10-20
Is primary listing	Yes
Is SPAC	No
ISIN number	US4500561067
Last 10-K release date	2026-02-19
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$4.1B
Market cap category	Mid-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$123.96
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	IRTC
U.S. state	California
Website	https://www.irhythmtech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	269.48x
Earnings yield	-0.35%
EV/EBIT	395.31x
EV/EBITDA	239.13x
EV/FCF	108.56x
EV/Sales	5.13x
FCF / EV yield	0.92%
FCF yield	0.95%
Forward EV/Sales	4.41x
Forward P/E	194.06x
Forward P/S	4.27x
Industry forward P/E	19.81x
Industry P/E	39.28x
P/(OCF - SBC) ratio	1,735.31x
P/B ratio	21.92x
P/FCF ratio	105.07x
P/OCF ratio	47.62x
P/S ratio	4.96x
Price / tangible book value	22.12x
Price/EBITDA ratio	231.44x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.3%
EBITDA margin	2.14%
FCF margin	4.72%
Gross margin	71.45%
Operating margin	1.3%
Pretax margin	-1.57%
Profit margin	-1.69%
Profit per employee	$-5,811
Revenue per employee	$343,890
ROA	0.65%
ROA (5Y)	-9.38%
ROCE	1.19%
ROE	-9.63%
ROE (5Y)	-48.81%
ROIC	0.76%
SBC / revenue	10.13%
Tax / revenue	0.12%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	7
EPS growth years	2
FCF growth	39.8%
FCF growth (Q)	116.98%
Gross profit growth	28.59%
Gross profit growth (Q)	22.84%
Gross profit growth 3Y	23.7%
Gross profit growth 5Y	22%
Net income growth quarters	7
Net income growth years	2
OCF growth	35.76%
OCF growth (Q)	84.68%
Revenue growth	25.58%
Revenue growth (Q)	20.08%
Revenue growth (QoQ)	12.43%
Revenue growth 10Y	32.69%
Revenue growth 3Y	22.22%
Revenue growth 5Y	21.92%
Revenue growth quarters	24
Revenue growth years	11

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-47M
Depreciation and amortization	$7M
EBIT	$10.7M
EBITDA	$17.7M
EPS	$-0.43
FCF per share	$1.18
Financing cash flow	$8M
Free cash flow	$39M
Free cash flow minus SBC	$-44.7M
Gross profit	$589.7M
Income taxes	$971,000
Investing cash flow	$-156.4M
Net borrowing	$-3,000
Net cash flow	$-62.4M
Net income	$-13.9M
Operating cash flow minus SBC	$2.4M
Operating income	$10.7M
Revenue	$825.3M
Stock-based compensation	$83.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.54
Book value per share	$5.65
Debt / EBITDA	24.37
Debt / equity	3.91
Debt / FCF	18.66
Goodwill	$862,000
Interest coverage	0.81
Long-term assets	$337.5M
Long-term liabilities	$711.3M
Net cash (debt)	$-136.1M
Net cash / market cap	-3.32%
Net debt / EBITDA	7.69
Net debt / equity	0.73
Net debt / FCF	3.49
Piotroski F-Score	5
Property, plant and equipment	$204.1M
Shareholders' equity	$186M
Tangible book value	$185.1M
Tangible book value per share	$5.62
Total assets	$1.1B
Total cash	$591.3M
Total debt	$727.3M
Total liabilities	$907.4M
WACC	10.62%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.8
Current assets	$756M
Current liabilities	$196.1M
Current ratio	3.85
Inventory turnover	11.52
Net working capital	$-14.5M
Quick ratio	3.65
Working capital	$559.9M
Working capital turnover	1.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.89%
Dividend yield	0%
Shareholder yield	-2.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	395.44%
10Y return CAGR	17.36%
10Y total return	395.44%
150-day SMA	$116.56
1D price change	0.17%
1M price change	12.3%
1M total return	12.3%
1W price change	9.17%
1W total return	9.17%
1Y price change	-32.15%
1Y return CAGR	-32.17%
1Y total return	-32.15%
20-day SMA	$111.90
200-day SMA	$122.72
3M price change	10.53%
3M total return	10.53%
3Y price change	58.54%
3Y return CAGR	16.6%
3Y total return	58.54%
50-day SMA	$115.07
50-day SMA vs 200-day SMA	50under200
52-week high	$212.00
52-week high date	2025-10-31
52-week low	$100.70
52-week low date	2026-10-08
5Y price change	80.33%
5Y return CAGR	12.52%
5Y total return	80.33%
6M price change	-1.59%
6M total return	-1.59%
All-time high	$286.19
All-time high date	2021-01-27
All-time low	$22.16
All-time low date	2016-11-03
Average true range (ATR)	$4.30
Average volume	467.8K
Beta (1Y)	0.92
Beta (2Y)	0.75
Beta (5Y)	1.46
Change from 52-week high	-41.53%
Change from 52-week low	23.1%
Change from all-time high	-56.69%
Change from all-time low	459.39%
Change from open	0.86%
Day's gap	-0.69%
Dollar volume	$58.3M
High price	$125.40
Low price	$122.85
Monthly RSI	48.98
Open price	$122.90
Position in 52-week range	43.53%
Premarket change	-0.55%
Premarket close	$123.75
Premarket price	$123.07
Previous close	$123.75
Price vs 150-day SMA	6.35%
Price vs 20-day SMA	10.78%
Price vs 200-day SMA	1.01%
Price vs 50-day SMA	7.72%
Relative volume	1.03
RSI	69.86
Sharpe ratio	-0.77
Sharpe ratio (3Y)	0.45
Sharpe ratio (5Y)	0.41
Sortino ratio	-0.93
Sortino ratio (3Y)	0.83
Sortino ratio (5Y)	0.82
Volume	470.1K
Weekly RSI	52.84
YTD price change	-30.14%
YTD total return	-30.14%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30.3M
Float percentage	91.88%
Shares change (QoQ)	1.19%
Shares change (YoY)	2.89%
Shares held by insiders	1.5%
Shares held by institutions	100.13%
Shares outstanding	33M
Short % of float	10.22%
Short % of shares	9.39%
Short ratio	5.6 days

Deeper analysis on IRTC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this IRTC report

Is a complete IRTC research report available?

No complete published report is available for iRhythm Holdings, Inc. (IRTC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

iRhythm Holdings, Inc. (IRTC)

Price

Financial snapshot

Fair-value bridge

Latest news · IRTC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IRTC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IRTC

Frequently asked questions